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Abstract
The combination of stem cell therapy and nanoparticles promises to enhance the effect of cellular therapies by using nanocarriers as
drug delivery devices to guide the further differentiation or homing of stem cells. The impact of nanoparticles on primary cell types
remains much more elusive as most groups study the nanoparticle–cell interaction in malignant cell lines. Here, we report on the
influence of polymeric nanoparticles on human hematopoietic stem cells (hHSCs) and mesenchymal stem cells (hMSCs). In this
study we systematically investigated the influence of polymeric nanoparticles on the cell functionality and differentiation capacity
of hHSCs and hMSCs to obtain a deeper knowledge of the interaction of stem cells and nanoparticles. As model systems of
nanoparticles, two sets of either bioinert (polystyrene without carboxylic groups on the surface) or biodegradable (PLLA without
magnetite) particles were analyzed. Flow cytometry and microscopy analysis showed high uptake rates and no toxicity for all four
tested particles in hMSCs and hHSCs. During the differentiation process, the payload of particles per cell decreased. The PLLA–Fe
particle showed a significant increase in the IL-8 release in hMSCs but not in hHSCs. We assume that this is due to an increase of
free intracellular iron ions but obviously also depends on the cell type. For hHSCs and hMSCs, lineage differentiation into erythro-
cytes, granulocytes, and megakaryocytes or adipocytes, osteocytes and chondrocytes, was not influenced by the particles when
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analyzed with lineage specific cluster of differentiation markers. On the other hand qPCR analysis showed significant changes in
the expression of some (but not all) investigated lineage markers for both primary cell types.
Introduction
Interaction of different stem cell types with nanomaterials has
been of interest lately for several reasons. One of the reasons is
that nanoparticles (materials with dimensions well below the
micrometer range) have been proposed for labeling of primary
cells, including stem cells, in order to study homing and
engraftment [1,2] or to deliver drugs. Labeling with iron-
containing particles provides the possibility to track the cell fate
in vivo by using noninvasive magnetic resonance imaging
(MRI). Superparamagentic iron oxide particles (SPIONs) are
used for this purpose but also gadolinium-loaded nanotubes can
be rendered magnetic with the objective of keeping the stem
cells at a desired place in the human body [3]. More advanced
approaches address the delivery of drugs or other agents into
stem cells [4,5], as stem cells are regularly processed ex vivo
and are therefore amenable to further treatment. Here, nanoma-
terials could provide a means of manipulating the fate of the
stem cells, for example, by influencing migration in vivo by
(over-)expression of homing receptors or influencing stem cell
differentiation by providing the cells with an intracellular depot
of a drug or a nucleic acid construct with slow release kinetics.
Thus, the intended nanoparticles should be tested for toxicity
and the nanomaterial as a carrier ideally should not influence
cellular functions itself, that is, only the payload should exert
such an effect. Once introduced into the system, toxicity can
occur from the nanoparticles themselves or from the associated
components of the nanoparticles that might be released during
degradation in vivo. In addition to potentially causing toxicity
after cellular uptake, nanoparticles could also alter cellular func-
tions such as the differentiation potential or secretion profile of,
for example, cytokines. The evaluation of these risks is a mile-
stone for the combination of nanomaterials with stem cells. One
of the most widely studied stem cell populations is undoubtedly
the human hematopoietic stem cell (hHSC), which has been
successfully used for many years for the treatment of leukemia
and lymphoma as well as for other, non-malignant diseases such
as aplastic anemia. Toxicity and cell functionality studies with
hHSCs and nanoparticles are rare and have been performed
only for a few different particle/material combinations [6-9]. As
these were not studied side-by-side, comparison of the results is
not commensurable.
Human mesenchymal stem cells (hMSCs) are a promising tool
for cell-based therapeutic strategies because they can be isolated
and expanded to high numbers in vitro, they possess the ability
to self-renew and the differentiation capacity towards lineages
are interesting for regenerative therapy (reviewed in [10]).
Furthermore, they are hypoimmunogenic, which makes them
suitable for allogeneic transplantations and they can even have
immunosuppressive functions [11,12]. hMSCs are fibroblast-
like cells that were first described by Friedenstein and
colleagues [13] and can be obtained from various tissues
including bone marrow [14], adipose tissue [15] and most
connective tissues [16]. Due to their ability to differentiate
towards adipocytes, chondrocytes and osteocytes [14], these
cells are also of a great interest for tissue engineering
approaches (e.g., for defects of bone or cartilage). Over 100
clinical trials employing hMSCs for regenerative medicine, for
instance, after stroke and myocardial infarction [17], demon-
strate that the clinical use of these cells is of utmost interest.
Therefore, the combination of nanoparticles with these two
stem cell types derived from the bone marrow is very promising
not only for labelling to monitor biodistribution and migration
of stem cells but also to establish the “pharmacokinetics” of
such cellular therapeutics. Furthermore, such nanoparticles can
be potentially used as carriers for drugs to influence the stem
cell fate once they have been delivered into a patient. For all of
these applications, the nanoparticle should act only as a delivery




Two sets of nanoparticles were chosen for this study: non-func-
tionalized polystyrene (PS) and carboxy-functionalized poly-
styrene (PS–COOH). PS–COOH particles are biocompatible,
but nondegradable particles whereas poly(L-lactide) particles
without (PLLA) and with magnetite (PLLA–Fe) are biocompat-
ible and biodegradable. All particles were fluorescently labeled
with the fluorescent dye N-(2,6-diisopropylphenyl)perylene-3,4-
dicarboximide (PMI). The magnetite was encapsulated for
magnetic resonance purposes. The polymeric nanoparticles used
in this work were obtained by miniemulsion polymerization
(non-functionalized and functionalized polystyrene nanoparti-
cles as described in [18]) or by a combination of miniemulsion
and emulsion/solvent evaporation techniques (PLLA nanoparti-
cles without and with magnetite, as described in [19,20]). In all
cases, SDS was used as a surfactant for the synthesis or forma-
tion of the nanoparticles. The nanoparticles were purified from
the surfactant excess by dialysis using Amicon Ultra membrane
filters with MWCO 100 kDa (Millipore). The main characteris-
tics of the nanoparticles are described in Table 1.
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Table 1: Characterization of the nanoparticles.








PMI 8.7 × 104 121 −46
PS polystyrene PMI 116 −45
PLLA–Fe PLLA
(140,000 g/mol)






aPMI (fluorescent dye), N-(2,6-diisopropylphenyl)perylene-3,4-dicarboximide.
Figure 1: (A) Nanoparticle uptake after 24 h incubation of hMSCs with 300 µg/mL nanoparticles analyzed by flow cytometry. Fluorescence [a.u.] =
median fluorescence intensity, arbitrary units. All cells with nanoparticles show a significantly higher fluorescence intensity compared to the negative
control (three independent experiments, p < 0.05). (B) Cytotoxicity study of the nanoparticles after 24 h incubation with 300 µg/mL particles analyzed
by 7-AAD staining and flow cytometry. Dead cells were not included in the analysis because they constituted less than 1%. The amount of apoptotic
cells is given in Supporting Information File 1, Figure S1.
Uptake and toxicity of polymeric nanoparti-
cles
Before the nanoparticles were used for differentiation studies,
cellular uptake and cytotoxicity of the particles were quantita-
tively determined by flow cytometry.
After incubation with 300 µg/mL nanoparticles for 24 h,
hMSCs showed a reasonable uptake of polystyrene nanoparti-
cles (PS, Figure 1A). Since here only one population was
detected in flow cytometry, the data are given as median fluo-
rescence intensity (MFI).
Functionalization of the nanoparticles with carboxy groups on
the surface leads to a 3-fold increase in particle uptake for
PS–COOH. The positive effect of surface functionalization on
the uptake for hMSCs with carboxy groups has been previously
demonstrated [18]. In addition to the good uptake properties,
the polystyrene particles did not have any cytotoxic effect
(Figure 1B). The biodegradable PLLA nanoparticles also
showed good uptake and no cytotoxic effects (Figure 1A,B).
This was also true for nanoparticles with iron oxide (magnetite)
embedded (PLLA–Fe). Confocal laser scanning microscopy
(cLSM) was performed to determine the intracellular localiza-
tion of the nanoparticles. The images in Figure 2 clearly show
Figure 2: Particle uptake into hMSCs detected by cLSM after 24 h
incubation with 300 µg/mL nanoparticles. (A) PS, (B) PS–COOH, (C)
PLLA, (D) PLLA–Fe. The cell membrane is stained with CellMask
Orange (red), nanoparticles are depicted in green, the cell nucleus is
stained with DraQ5 and is pseudo-colored in blue. The white scale bar
represents 25 µm.
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Figure 3: Particle uptake of hHSCs after 24 h incubation with 300 µg/mL nanoparticles. The nanoparticle content was measured every 2 days during
differentiation time. Gating was based on FSC/SSC in order to exclude debris. Further gating was based on the differentiation markers for the erythro-
cyte lineage (CD71, CD235a), granulocytic lineage (CD11b, CD15) and megakaryocytic lineage (CD41a, CD42b).
that all particle types were indeed internalized by the cells and
not only attached to the cell surface.
hHSCs showed a reasonable uptake of the polystyrene nanopar-
ticles after incubation with 300 µg/mL nanoparticles for 24 h
and an even greater uptake for the PLLA particles. All four
particles showed a double population in the fluorescence
histogram for hHSCs, pointing to the possibility that there are
still several subsets within the CD34+ selected hHSCs that
differ in their ability to take up nanoparticles (Figure 3).
Notably, although two populations of hHSCs were detected, all
cells in the two populations showed a fluorescence intensity
above the background level of the negative control, demon-
strating that cells in both populations had taken up nanoparti-
cles. The cLSM results for the hHSCs clearly showed that parti-
cles were incorporated (Supporting Information File 1, Figure
S2).
During the differentiation time of 11 days, the cells in all
lineages showed a pronounced loss of the fluorescence signal
and therefore of nanoparticles. This was very much expected as
the proliferation of hHSCs during the growth factor induced dif-
ferentiation will decrease the amount of nanoparticles per cell
division by a factor of 1/2. For the PLLA particles, the
remaining amount was significantly higher than the negative
control even after 11 days. In the case of the PS particles, the
remaining number of nanoparticles after 11 days was lower, and
the PS–COOH were indistinguishable from the negative control
for megakaryocytic and also from the granulocytic differenti-
ation. The PS and as well the PLLA particles did not show any
detectable toxicity (Supporting Information File 1, Figure S3).
Cytokine secretion of hMSCs and hHSCs
To determine if the polymeric nanoparticles have an impact on
the cell functionality, IL-6 und IL-8 were chosen as they have
been reported to be secreted by hMSCs [21,22]. The concentra-
tion of these two cytokines was measured with a HTRF® assay.
Cells were incubated with 300 µg/mL nanoparticles for 24 h,
and excess particles were washed away. Then the cells were in-
cubated in fresh medium for 5 days and the supernatant was
used for the HTRF® measurements. The polystyrene particles
did not influence the IL-6 or IL-8 secretion (Figure 3). The lone
PLLA particles also showed no influence on the cytokine secre-
tion. In contrast, the PLLA–Fe particles dramatically increased
the IL-8 release while the IL-6 secretion was not altered
(Figure 4).
For hHSCs, cell functionality was tested by quantitative
analysis of the IL-8 secretion. Cells were incubated with
300 µg/mL nanoparticles for 24 h and afterwards cells were
washed three times with PBS− and cultivated for 5 days in a
medium with SCF and Flt. IL-8 secretion was measured in the
supernatant at the end of this cultivation period. The secretion
level of IL-8 was not significantly altered in the presence of the
polymeric nanoparticles (Supporting Information File 1, Figure
S4).
Differentiation behavior under nanoparticle
influence
Cytochemical staining of hMSCs
For analyzing the particle influence on the differentiation
capacity of hMSCs, the cells were incubated with 300 µg/mL
nanoparticles for 24 h before starting the differentiation by
providing the adequate differentiation medium. After 24 days,
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Figure 4: Cytokine secretion of hMSCs treated with different nanoparticles: (A) IL-6, (B) IL-8. hMSCs were incubated with 300 µg/mL particles for 24
h, cytokine detection was performed after 5 days of cultivation with a HTRF assay by analyzing the cell culture supernatant. p > 0.05 ns, p < 0.001 ***.
Figure 5: Cytochemical staining to determine the differentiation of hMSCs incubated with different nanoparticles (300 µg/mL nanoparticles, incuba-
tion time 24 h, before inducing differentiation). Osteogenic differentiation was demonstrated by alkaline phosphatase activity, chondrogenic differenti-
ation by methylene blue staining of the extracellular matrix, and adipogenic differentiation by Oil-Red O staining of the lipid droplets. Samples without
particle incubation (without particles) served as controls. The black scale bar represents 200 µm (except for adipo and non-differentiated samples,
100 µm).
osteogenic and chondrogenic differentiation was analyzed by
detecting alkaline phosphatase activity or methylene blue
staining, respectively. Detection of adipogenic differentiation
was performed after 4 weeks with Oil-Red O staining. In the
presence of the nanoparticles, the differentiation into the three
investigated lineages was not affected, as determined by cyto-
chemical staining (Figure 5).
The detection of the extracellular matrix for the chondrogenic
differentiation, the alkaline phosphatase activity for the
osteogenic differentiation, as well as the lipid droplets for the
adipogenic differentiation showed the same characteristics as
the sample without nanoparticles. To investigate if the presence
of polymeric nanoparticles can induce differentiation without
the use of specific media, the same differentiation experiment
was performed for differentiation media, but the cells were kept
in α-MEM for the entire time. These samples were labeled
as “non-differentiated”. The particles also show no
indication of the onset of the differentiation process in the
absence of the specific differentiation media. No specific differ-
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Figure 6: Influence of polystyrene nanoparticles (PS and PS–COOH) on the expression of adipogenic and osteogenic marker genes in hMSCs.
Expression was analyzed with qPCR, using GAPDH and B2M as an internal control. The normalized fold expression was calculated with the ΔΔCT
method, assigning the non-differentiated sample without particle as a control. p > 0.05 ns, p < 0.05 *, p > 0.01 **; FABP4: fatty acid binding protein 4;
TIMP: tissue inhibitor of metalloproteinase; CIDE: cell death inducing DFFA-like effector.
entiation evidence could be detected with the cytochemical
staining.
qPCR analysis of the expression of the different
lineage markers for hMSCs
To assess whether the polymeric nanoparticles had an influence
on the expression of marker genes during the differentiation,
qPCR analysis on cDNA from RNA extracted from differenti-
ated and non-differentiated samples was performed. The non-
functionalized PS particle significantly decreased the expres-
sion of the adipogenic markers FABP4 and TIMP in the non-
differentiated samples. The carboxy functionalized PS–COOH
nanoparticles, in contrast, had no influence on the expression of
the marker genes in the non-differentiated samples. For the
differentiated samples, both particles showed a significant
decrease of the expression level of TIMP, and the other two
lineage markers were not affected (Figure 6).
The presence of PLLA and PLLA–Fe particles during the
adipogenic differentiation showed no impact on the expression
level of these lineage markers (Figure 7).
The expression of the osteogenic lineage marker ALPI II is
influenced by the presence of the PS nanoparticles but not by
the PS–COOH nanoparticles (Figure 6). Interestingly, the
expression of ALPI II is significantly upregulated in the non-
differentiated samples, and in the differentiated samples, there
is a significant decrease in ALPI II expression. The expression
of osteopontin was not altered in the presence of polystyrene
nanoparticles. In the case of the PLLA particles, only the
expression of osteopontin is significantly reduced in the non-
differentiated samples for the PLLA–Fe particles. Although
statistically different, the relevance of an expression level of
approximately 0.6 compared to the control is not impressive and
may not be strong enough to divert further development. All
other expression values are not affected by the presence of these
particles (Figure 7).
Differentiation in flow cytometry for hHSCs
Differentiation of hHSCs in three lineages was determined after
incubation with 300 µg/mL nanoparticles with CD marker
expression analysis and qPCR. All three lineages showed no al-
teration in CD marker expression after the incubation with all
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Figure 7: Influence of polylactide nanoparticles (PLLA and PLLA–Fe) on the expression of adipogenic and osteogenic marker genes in hMSCs.
Expression was analyzed with qPCR, using GAPDH and B2M as internal controls. The normalized fold expression was calculated with the ΔΔCT
method, assigning the non-differentiated sample without nanoparticles as a control. p > 0.05 ns, p < 0.05 *.
four polymeric nanoparticles (Supporting Information File 1,
Figures S5,S6). All CD markers were clearly expressed at a
higher level after the differentiation, which indicated a correct
lineage differentiation.
qPCR analysis of the expression of the different
lineage markers for hHSCs
When analyzing at the RNA level for differentiation markers
for hHSCs, several changes in the expression level were
observed. In all three differentiation lineages, the polystyrene
particles significantly altered the expression of some but not all
differentiation markers. The PS particles only caused a signifi-
cant increase in the expression of the granulopoetic marker
ILRA (Figure 8). Although we did not carry out further analysis
at the protein level, it seems to be worthwhile to perform an
ELISA for ILRA where nanoparticles are used to label hHSCs
or granulocytes or where nanoparticles are used to deliver drugs
or other molecules into hHSCs or granulocytes.
The PS–COOH particles altered the expression of marker genes
of all three lineages. The pure PLLA particles did not influence
the expression of any of the investigated marker genes
(Figure 9). In contrast, the PLLA–Fe particles had a strong
influence on some marker genes. The expression of glycophorin
A was significantly increased by the presence of the PLLA–Fe
particles, whereas the expression of both granulopoetic markers
was significantly suppressed.
Discussion
Although nanoparticles are proposed as useful drug and DNA
or siRNA delivery vehicles (which could potentially change the
fate of stem cells), they could also influence the cellular fate of
stem cells with a potentially devastating effect. While hMSCs
have been used in many studies, only a limited number of
studies with these cells have been undertaken [1]. Cells labeled
with superparamagnetic nanoparticles can be tracked after trans-
plantation using MRI methods [23]. This approach allows for a
deeper knowledge about the biological distribution of the
engrafted cells in the body to be gained. While some nanoparti-
cles may have no or little effect on viability and differentiation
[24], some nanoparticles may tend to guide the differentiation
towards a desired lineage without the need of specific growth
Beilstein J. Nanotechnol. 2015, 6, 383–395.
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Figure 8: qPCR results of polystyrene particles in hHSCs. Carboxy-functionalized polystyrene particles PS–COOH showed a slight increase in
glycophorin A, TREM and ILRA transcription, while a decrease for CAECAM was observed. For pure polystyrene, only ILRA was increased.
Figure 9: qPCR results of the polylactide particles in hHSCs. For glycophorin A, a significant increase could be detected when PLLA–Fe particles
were used. On the other hand, the granulocytic markers CAECAM and ILRA were suppressed with PLLA–Fe particles.
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factors [25]. As a second step, the cells could be loaded with
drugs containing particles for enhancing the differentiation in
one direction or improving the graft efficiency [26,27]. Before
using these complex nanoparticle systems, all potential risks
(e.g., toxicity and alteration in cell functionality) concerning the
material, surface functionality, etc. should be investigated. Ad-
ditionally, even for industrial applications (e.g., coatings in
automotive and other types of industries) toxicology studies are
warranted. In this study, we demonstrated that polystyrene and
polylactide particles are taken up not only by hMSCs, but also
at a reasonable amount by hHSCs. This is itself interesting as
hHSCs have no phagocytotic properties, and the endocytotic
processes in hHSCs are not known for a high turnover rate.
Flow cytometry analysis showed that the particle uptake differs
between the two materials, polystyrene and polylactide. Poly-
lactide particles are taken up at a higher concentration in both
cell types compared to polystyrene particles, demonstrating the
comparative investigation of different materials. The surface
functionalization of the PS–COOH particles led to an increase
of the particles in hMCS, but this was less effective in hHSCs.
The hHSCs showed a great loss in particle payload during all
three lineage differentiations. This is likely due to the high
proliferation rates during the differentiation process. In other
studies, this dilution due to proliferation activity of the cells has
clearly been shown [28,29]. In the literature, the interaction of
hHSCs and nanoparticles is poorly investigated, probably due to
the lack of adequate material in many laboratories. There are
some studies with particles containing iron for cell labeling for
MRI measurements. In different studies with the MRI contrast
agent Ferridex® (iron oxide with a dextran shell), no toxicity
and normal differentiation behavior was shown for hHSCs
[6-8]. A study with diverse inorganic nanoparticles of different
sizes showed distinct toxicity for some particles (cobalt, anti-
mony oxide) as well as some negative influence on the differen-
tiation process [9]. For polymeric nanoparticles and hHCSs,
there are no studies currently available to the authors’ knowl-
edge. Since hMSCs constantly secreted IL-6 and IL-8 [21,22],
we therefore investigated these two cytokines. Whereas the
secretion of IL-6 was not influenced at all by the polymeric
nanoparticles, the secretion of IL-8 was dramatically increased
in the presence of the PLLA–Fe particles in hMSCs. This is
likely because of the release of iron ions from the particles. Free
iron ions within the cell can lead to an increase in oxidative
stress [30-32], and a higher level of reactive oxygen species
(ROS) can lead to an increased release of IL-8. The observation
of an increased IL-8 release has also been reported for silver
ions/nanoparticles [33] with hMSCs. For hHSCs, no increase of
IL-8 release was observed.
Clearly, the effect on differentiation of hMSCs should be
investigated separately from toxicity as Liu et al. demonstrated
that even for toxic nanoparticles, differentiation may not be
affected [34] while Hou et al. showed that TiO2 nanoparticles
do affect viability and differentiation [35]. To explore whether
the particles could disrupt the differentiation process, the differ-
entiation efficiency was qualitatively and quantitatively
analyzed. In the case of hMSCs lineage differentiation, this
study clearly showed that in the presence of all four particles,
adipogenic, chondrogenic and osteogenic differentiation charac-
teristics were correctly developed when cytochemical staining
was performed. In the case of adipogenic differentiation, lipid
droplets could be visualized with Oil-red O, the extracellular
matrix developing during chondrogensis could be detected with
methylene blue staining and, in the case of osteogenic differen-
tiation, the activity of alkaline phosphatase was clearly visible.
For an application of nanoparticles in cell-based therapies it is
also important that the hMSCs do not lose their self-renewal
potential without undergoing differentiation. In this work, we
did not see any particle-induced differentiation by itself.
The qualitative analysis of hHSC differentiation showed that the
expression of lineage specific CD markers for hHSCs was not
altered in the presence of the particles. However, when the
expression levels of several differentiation markers was
analyzed by qPCR, the expression of some but not of all
markers were affected. Especially interesting is the high expres-
sion of glycophorin A, which indicates that the erythrocyte dif-
ferentiation is enhanced with PLLA–Fe particles. This can be
explained by the fact that iron in this case is an essential com-
pound for erythrocyte differentiation and, therefore, enhances
proliferation in this direction, while other lineages do not
require it and it may even have a negative effect such as
producing reactive oxygen species (ROS).
For hMSCs, despite of detecting no obvious difference between
treated and untreated samples with cytochemical staining, the
pPCR analysis showed some alteration in the expression level
of the genes investigated. The influence on the expression of
different marker genes varied between the particles. Whereas
both polystyrene particles led to some down regulation of the
adipogenic markers FABP4 and TIMP, all of the polylactide
particles did not have an influence on these adipogenic markers.
The adipogenic marker CIDE 3 was not influenced by all of the
particles. With regards to the osteogenic markers, the situation
is similar: the non–functionalized PS particle affects the expres-
sion of ALP in the non–differentiated samples as well as in the
differentiated, whereas the carboxy-functionalized PS–COOH
and PLLA did not influence the expression of all osteogenic
markers. The PLLA–Fe particle has some impact on the expres-
sion of another osteogenic marker, osteopontin. Taken together
this implies that a strong influence on the differentiation of
hMSCs is unlikely for the nanoparticles investigated.
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Therefore, for hMSCs as well as for hHSCs, longer in vivo
studies are crucial to determine if the influence seen in the
comparably short in vitro assays also has a functional conse-
quence (e.g., for engraftment after transplantation or cell dose
needed for a stable engraftment).
In the complex process of hMSC and hHSC differentiation, it is
hard to determine at which point the particle influence takes
place. As we observed some gene expression changes, a closer
look at the molecular level of the interaction between nanoparti-
cles and cells should be the aim of future research to obtain
more information about the use of nanoparticles. Furthermore, a
closer look into the signaling pathways and how they are
affected by nanoparticles is a challenging but necessary task for
further understanding of the underlying processes.
Conclusion
The present study clearly showed that hMSCs and hHSCs are
able to take up different polymeric particles at a reasonable
concentration without showing any signs of toxicity. The
surface functionalization of the polystyrene particle with
carboxy groups did not improve the cellular uptake for hHSCs,
while for hMSCs, this effect was confirmed. The secretion of
IL-8 as a demonstration of cell functionality was not altered in
the presence of either polystyrene or polylactide particles for
hHSCs, but was for hMSCs. During the differentiation process,
the cells showed a significant reduction in nanoparticle concen-
tration due to high proliferation rates. The differentiation into
the respective investigated lineages showed no alteration when
analyzed by qualitative methods. However, the qPCR analysis
of some lineage markers showed alterations in the expression
level of some but not all markers for hHSCs and for hMSCs,




Polystyrene particles were obtained via the miniemulsion
process as previously described in [18]. Polylactide particles
were obtained by a combination of miniemulsion and emulsion/
solvent evaporation techniques as previously described in
[19,20]. Particle characteristics are given in Table 1.
Isolation of human hematopoietic stem cells
(hHSCs)
hHSCs were obtained via apheresis from peripheral blood
(peripheral blood stem cells, PBSC) for validation purposes of
another study after obtaining informed consent. The apheresis
product was selected for CD34+ stem cells by the CliniMACS
procedure as part of an established routine process in the Stem
Cell Laboratory (“Herstellungslabor für Zelltherapie”) of the
University Medical Center of the Johannes Gutenberg Univer-
sity, Mainz. The portion of the CD34+ selected PBSC that was
not used for validation in the clinical study was approved by the
ethics committee of Rhineland-Palatinate to be used for our
study (approval number: 837.425.10 (7434)). A second
informed consent was obtained from the donors so that the ma-
terial could be used for our assays. The cells were stored in the
gas phase of liquid nitrogen always kept below −140 °C and
used fresh for every experiment.
For all experiments, the cells were seeded at a density of 0.5–2
× 106 cells/well in 12-well plates (Greiner Bio) of 3 mL
volume. As a basal medium, Iscove's Modified Dulbecco's
Medium (IMDM, Invitrogen) supplemented with 10% fetal calf
serum (FCS, Invitrogen), 100 units penicillin and 100 µg/mL
medium streptavidin (Invitrogen) were used. For cultivation
and differentiation, the cells were kept in a humidified
incubator with 5% CO2 at 37 °C. All experiments were
performed with cells incubated with 300 µg/mL nanoparticles
for 24 h.
Isolation and cultivation of human mesenchymal
stem cells (hMSCs)
MSCs were generated from bone marrow aspirations or
explanted hips after obtaining informed consent. The study was
approved by the ethics committee of the University Ulm,
Germany (approval number: 24/11). Primary human hMSCs
were generated as previously described [36].
MSC were cultivated in α–MEM (Lonza, Cologne, Germany)
supplemented with 20% fetal calf serum (FCS, Invitrogen, Karl-
sruhe, Germany), 100 units penicillin and 100 µg/mL medium
streptavidin (Invitrogen), 1 mM pyruvate (Invitrogen) and 0.6%
ciprofloxacin (Fluka, Buchs, Switzerland) in a humidified incu-
bator with 5% CO2 at 37 °C.
For particle uptake and cell viability experiments, cells were
seeded at a density of 10,000 cells/cm2 in 6-well plates (Greiner
Bio, Frickenhausen, Germany). After adherence, the cells were
incubated with 300 µg/mL nanoparticles for 24 h and analyzed
by flow cytometry.
Flow cytometry
Particle uptake, cell viability, and CD marker staining were
measured with a flow cytometer (FACS Canto II, BD, Heidel-
berg, Germany). The cells were washed with phosphate
buffered saline without calcium (PBS−, Invitrogen) and incu-
bated with 28.6 mg/mL 7-aminoactinomycin (7-AAD, Sigma,
Munich, Germany) for 15 min in the dark at room temperature
or with the respective antibody at 4 °C. The cells were washed
again with PBS− and flow cytometry was performed. All flow
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cytometric analyses were performed with FCS Express
(DeNovo Software, Los Angeles, CA, USA). The nanoparticle
dye perylenemonoimide (see [18] for structure and other
details) was excited with a 488 nm laser, and the signals was
acquired using a 530 ± 30 nm filter. 7-AAD or antibody-
coupled APC was excited with the 633 nm laser and the signals
were acquired using a 660±20 nm filter (7-AAD or APC). The
cells were analyzed by gating on a dotplot of the forward/side-
ward scatter and thereby excluding free particles and cell debris.
The nanoparticle uptake was analyzed in a PMI channel
histogram, and the 7-AAD signal in a 7-AAD/PMI channel
dotplot by setting three gates (vital, apoptotic, dead) and taking
the percentage of gated cells in the respective gate. Signals from
APC-coupled antibodies were analyzed by overlays of several
signals in die APC channel.
Confocal laser scanning microscopy (cLSM)
Confocal laser scanning microscopy was performed to validate
the intracellular localization of nanoparticles. Images were
taken with a Leica SP5 II with a 60× oil immersion objective.
The particle dye PMI was excited with the 488 nm laser, and
the emission was collected at 510–540 nm. The cell membrane
was stained with Cell Mask Orange according to the recommen-
dations of the manufacturer (Invitrogen), and excited with
543 nm laser light and the emission was collected at 565–585
nm. To avoid crosstalk between the channels, emission signals
were collected independently in serial mode.
Induction of differentiation for hHSCs
In vitro differentiation of hHSCs was performed as previously
described [37]. 1.5 × 106 fresh thawed cells were incubated
with 300 µg/mL nanoparticles in 3 mL of basal medium for 24
h in 12-well plates. Before inducing differentiation, the cells
were washed twice with PBS−. The cells were differentiated in
12-well plates in a volume of 3 mL of basal medium, supple-
mented with lineage-specific cytokines and growth factors (see
Supporting Information File 1, Table S1, all from R&D, USA).
After 11 days, 1 × 106 cells were used for RNA extraction, and
0.5 × 106 cells were used for CD marker staining and flow
cytometry analysis.
CD marker staining for hHSCs
To determine the differentiation status of hHSCs after 11 days,
lineage-specific, CD marker staining was performed as
described elsewhere [37]. Differentiation into the erythroid
lineage was shown with CD71 and CD235a, granulopoesis with
CD11b and CD15 and megakaryopoesis with CD41a and
CD42. Antibodies and isotype controls were obtained from BD
and Beckmann Coulter, Germany. Staining was performed in
50 µL PBS− for 15 min at 4 °C. The cells were washed with
PBS− and analyzed with flow cytometry.
Induction of differentiation for hMSCs
hMSCs were seeded in 6-well tissue culture plates (cytochem-
ical staining) or 12-well tissue culture plates (RNA isolation,
both Greiner Bio one, Frickenhausen, Germany) at 2 × 104
cells/cm2 for adipogenic or 0.5 × 104 cells/vm2 for chondro-
genic and osteogenic differentiation. Cells for adipogenic differ-
entiation were cultivated in α–MEM until confluence and then
differentiation was induced with Adipogenic Induction Medium
(Lonza, Cologne, Germany). The medium was changed twice a
week, altering between adipogenic induction medium and
adipogenic maintenance medium (Lonza, Cologne, Germany)
for 3 weeks, followed by one week of cultivation in
adipogenic maintenance medium. Osteogenic and chondro-
genic differentiat ion was induced using NH Osteo
Diff Medium/NH Chrondro Diff Medium (Miltenyi Biotec
Bergisch Gladbach, Germany); the medium was changed
twice a week. Analysis was performed after 24 days of cell
culture.
Before starting the differentiation, all cells were incubated with
300 µg/mL nanoparticles for 24 h and non-treated samples
served as a control. All experiments were also performed in
α–MEM without differentiation factors (non-differentiated
samples).
Cytochemical staining of hMSCs
Osteogenic differentiation was verified by detection of alkaline
phosphatase activity using SIGMAFASTTM BCIP®/NBT
tablets. Briefly, incubation with a solution containing an alka-
line phosphatase substrate results in a dark purple dye deposit,
indicating the sites of alkaline phosphatase activity in cells
differentiated into the osteogenic lineage. The extracellular
matrix developed during chondrogenic differentiation
was detected by staining with Loeffler´s methylene blue (Carl
Roth, Karlsruhe, Germany). Adipogenic differentiation was
detected by the lipophilic dye Oil Red O (Sigma Aldrich),
which stained the lipid droplets of adipocytes deep red. Hema-
toxylin–Harris was used for counter staining which stained the
cell nuclei blue.
Quantitative real time PCR (qPCR)
Total RNA was extracted from hHSCs or hMSCs using the
RNeasy Kit (Qiagen, Hilden, Germany) according to the manu-
factures instructions. For better cell dissociation, Qiashredder
columns (Qiagen, Germany) were used. RNA was transcribed
using iScript cDNA Synthesis Kit (Bio-Rad, Germany). The
concentration and quality of RNA and cDNA was determined
with a NanoDrop 8000 spectrometer (Nanodrop, Wilmington,
USA). qPCR reactions were done with an iQ SYBR® green
Supermix system (Bio-Rad) using the CFX96 Real-Time PCR
Detection System (Bio-Rad) with the following program: initial
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denaturation at 95 °C for 3 min, followed by 40 cycles of PCR
(95 °C for 10 s, annealing temperature (see Supporting Informa-
tion File 1, Tables S2 and S3) for 10 s and 72 °C for 30 s and
ending with a melting curve analysis (65 °C to 95 °C, incre-
ment 0.5 °C for 5 min). The primer sequences are given in
Supporting Information File 1, Tables S2 and S3. The primers
were used at a final concentration of 25 pmol/20 µL reaction.
The primer mix for 18s RNA was purchased from Tataa
Biocenter (Gothenburg, Sweden) and used in the recommended
concentration. Expression of 18s RNA was used to normalize
the gene expression level in hHSCs. For hMSCs, expression of
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and β2
microglobulin (B2M) was used to normalize the gene expres-
sion level. The relative difference in the expression level was
calculated using the ΔΔCT method, setting the expression in the
d0 sample as 1. The relative expression was used if d0 samples
did not show expression of the used marker gene and was calcu-
lated with the ΔCT method, setting the expression in the sample
without particles to 1.
HTRF Assay
The levels of IL-8 in the cell culture supernatant were quantita-
tively investigated with Human IL-8 HTRF® Assays (Cisbio
Bioassays, Codolet, France) using the cell-supernatant protocol
as recommended by the manufacturer. In brief, 0.5 × 106 cells
were seeded in 12-well plates and incubated with 300 µg/mL
nanoparticles for 24 h in basal medium. Afterwards, the cells
were washed 3 times with PBS− supplied with fresh medium
(basal medium supplemented with 50 ng/mL SCF and Flt) and
cultured for 5 days. The supernatants were collected and stored
at −80 °C until analysis. HTRF® was performed in 384-well,
low volume, flat bottom plates (Corning) according to the
manufactures instructions in a total volume of 20 µL. The fluo-
rescence signal was measured with an Infinite® M 1000 (Tecan,
Germany). The acquisition parameters were chosen according
to the manufacturer’s manual (donor settings: top fluorescence
mode, excitation 317 ± 0 nm, emission 620 ± 50 nm, integra-
tion time 500 µs, lag time 60 µs; acceptor settings the same
except emission 665 ± 50 nm). Data analysis was performed
with Magellan V6.6 software (Tecan) using a calibration curve
which was included in the kit.
Statistical analysis
The qPCR and HTRF data were analyzed with one-way
analysis of variance (ANOVA) followed by Tukey’s Multiple
Comparison Test (GraphPad Prism 5, GraphPad Software Inc.,
USA). Statistical differences of p < 0.05 were considered
significant. Significance is indicated in the figures as follows: p
> 0.05 ns (not significant), p < 0.05 *, p < 0.01 **, and p <
0.001 ***.
Supporting Information
Supporting Information File 1
Additional experimental results and material
characterization.
The file contains several additional results complementing
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